Skip to main content
SpringerLink
Log in
Book cover

Thérapeutique du cancer pp 327–339Cite as

Cancer de l’oesophage

  • Chapter

  • 770 Accesses

Résumé

Le pronostic du cancer de l’oesophage reste mauvais avec une survie globale à cinq ans inférieure à 20 % [1]. La prise en charge médicale des patients est complexe en raison d’une révélation de la maladie le plus souvent à un stade avancé chez des sujets âgés et/ou avec des pathologies sévères associées. Une particularité de ce cancer est la fréquence et l’intensité de la dénutrition au moment du diagnostic. La dénutrition est présente chez environ 80 % des patients et constitue un facteur pronostique majeur quel que soit le stade de la maladie [2]–[4].

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Keighley MRB (2003) Gastrointestinal cancers in Europe. Aliment Phamarcol Ther 18(suppl. 3): 7–30

    Article  Google Scholar 

  2. Riccardi D, Allen K (1999) Nutritional Management of Patients With Esophageal and Esophagogastric Junction Cancer. Cancer Control 6: 64–72

    PubMed  Google Scholar 

  3. Di Fiore F, Lecleire S, Pop D et al. (2007) Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 102: 2557–2563

    Article  PubMed  Google Scholar 

  4. Lecleire S, Di Fiore F, Antonietti M et al. (2006) Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer. Gastrointest Endosc 64: 479–484

    Article  PubMed  Google Scholar 

  5. Ferlay J, Bray F, Pisani P et al. (2001) Cancer incidence, mortality and prevalence worldwide, Version 1.0. IARC. CancerBase no 5. Lyon, IARCPress

    Google Scholar 

  6. Benhamiche AM, Colonna M, Aptel I et al. (1999) Estimation de l’incidence des cancers du tube digestifs par régions. Gastroenterol Clin Biol 23: 1040–1047

    PubMed  CAS  Google Scholar 

  7. Gallus S, Altieri A, Bosetti C et al. (2003) Cigarette tar yield and risk of upper digestive tract cancers: case-control studies from Italy and Switzerland. Ann Oncol 14: 209–213

    Article  PubMed  CAS  Google Scholar 

  8. Launoy G, Milan C, Faivre J et al. (1997) Alcohol, tobacco and oesophageal cancer. Effects of the duration of consumption mean intake, current and former consumption. Br J Cancer 75: 1389–1396

    Article  PubMed  CAS  Google Scholar 

  9. Launoy G, Milan C, Day NE et al. (1998) Diet and squamous cell cancer of the oesophagus: a french multicentre case-control study. Int J Cancer 76: 7–12

    Article  PubMed  CAS  Google Scholar 

  10. Launoy G, Milan C, Faivre J et al. (2000) Tabacco type and risk of squamous cell cancer of the esophagus in males: a French multicentre case-control study. Int J Epidemiol 29: 36–42

    Article  PubMed  CAS  Google Scholar 

  11. Enzinger PC, Mayer RJ. (2003) Esophageal Cancer. N Engl J Med 349: 2241–2252

    Article  PubMed  CAS  Google Scholar 

  12. Weikert C, Dietrich T, Boeing H et al. (2009) Lifetime and baseline alcohol intake and risk of cancer of the upper aero-digestive tract in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 125: 406–412

    Article  PubMed  CAS  Google Scholar 

  13. Paull A, Trier JS, Dalton MO et al. (1976) The histological spectrum of Barret’s oesophagus. N Engl J Med 295: 476–480

    Article  PubMed  CAS  Google Scholar 

  14. Chandrasoma P, Wickramasinghe K, DeMeester T (2007) Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia? Dis Esophagus 20: 36–41

    Article  PubMed  CAS  Google Scholar 

  15. Shaheen NJ, Richter JE. (2009) Barrett’s oesophagus. Lancet 373: 850–861

    Article  PubMed  CAS  Google Scholar 

  16. Schmitt CM, Brazer SR (1995) Clinical aspects of esophageal cancer. Gastrointestinal Cancer 91–114

    Google Scholar 

  17. Ikeda M, Nastugoe S, Ueno S et al. (2003) Significant host-and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg 328: 197–202

    Google Scholar 

  18. Bartels H, Stein HJ, Siewert JR et al. (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85: 840–844

    Article  PubMed  CAS  Google Scholar 

  19. O’Dwyer PJ, Johnson SW, Hamilton TC (1997) Cisplatin and its analogues. In: Cancer, principles and practice of oncology, 5th ed. Devita VT, Hellman S, Rosenberg. Ed Lippincott-Raven, p. 418–431

    Google Scholar 

  20. Tio TL, Coene PP, Den Hartog et al. (1990) Preoperative TNM classification of esophageal carcinoma by endosonography. Hepato-gastroenterol 37: 376–381

    CAS  Google Scholar 

  21. Kelly S, Harris K, Berry E et al. (2001) A systematic review of the staging performance of endoscopic ultrasound in gastro-esophageal carcinoma. Gut 49: 534–539

    Article  PubMed  CAS  Google Scholar 

  22. Vasquez-Sequeiros E, Wiersema MJ, Clain JE et al. (2003) Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 125: 1883–1886

    Article  Google Scholar 

  23. Flamen P, Van Cutsem E, Lerut A et al. (2002) Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 13: 361–368

    Article  PubMed  CAS  Google Scholar 

  24. Rankin SC, Taylor H, Cook GJ et al. (1998) Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Clin Radiol 53: 659–665

    Article  PubMed  CAS  Google Scholar 

  25. Lerut T, Flamen P, Ectors N et al. (2000) Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232: 743–752

    Article  PubMed  CAS  Google Scholar 

  26. Pan LL, Gu P, Huang G et al. (2009) Prognosis significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and metaanalysis. Eur J Gastroenterol Hepatol in press

    Google Scholar 

  27. Seewald S, Omar S, Soehendra N (2007) Endoscopic mucosectomy of the esophagus. Am J Gastroenterol 102: 236–238

    Article  PubMed  Google Scholar 

  28. Tanabe S, Koizumi W, Higuchi K et al. (2008) Clinical outcomes of endoscopic oblique aspiration mucosectomy for superficial esophageal cancer. Gastrointest Endosc 67: 814:20

    Article  PubMed  Google Scholar 

  29. Greenstein AJ, Wisnivesky JP, Litle VR (2008) Effect of local therapy for the treatment of superficial esophageal cancer in non-operative candidates. Dis Esophagus 21: 673–678

    Article  PubMed  CAS  Google Scholar 

  30. Hulscher JB, van Sandick JW, de Boer AG et al. (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347: 1662–1669

    Article  PubMed  Google Scholar 

  31. Earlam R, Cunha-Melo JR. (1980) Oesophageal squamous cell carcinoma: II. A critical review of radiotherapy. Br J Surg 67: 457–461

    Article  PubMed  CAS  Google Scholar 

  32. Muller JM, Erasmi H, Stelzner M et al. (1990) Surgical therapy of oesophageal carcinoma. Br J Surg 77: 845–857

    Article  PubMed  CAS  Google Scholar 

  33. Nigro JJ, DeMeester SR, Hagen JA et al. (1999) Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 117: 960–968

    Article  PubMed  CAS  Google Scholar 

  34. Ando N, Ozawa S, Kitagawa Y et al. (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232: 225–232

    Article  PubMed  CAS  Google Scholar 

  35. Lerut T, de Leyn P, Coosemans W et al. (1994) Advanced esophageal carcinoma. World J Surg 18: 379–387

    Article  PubMed  CAS  Google Scholar 

  36. Holscher AH, Bollschweiler E, Bumm R et al. (1995) Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 118: 845–855

    Article  PubMed  CAS  Google Scholar 

  37. Triboulet JP (1999) Traitement chirurgical du cancer épidermoïdes de l’oesophage. Gastroenterol Clin Biol 23: 507–512

    PubMed  CAS  Google Scholar 

  38. Kawahara K, Maekawa T, Okabayashi K et al. (1998) The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol 67: 160–163

    Article  PubMed  CAS  Google Scholar 

  39. Kelsen DP, Ginsberg R, Pajak TF et al. (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339: 1979–1984

    Article  PubMed  CAS  Google Scholar 

  40. MRC (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. The Lancet 359: 1727–1733

    Article  Google Scholar 

  41. Malthaner RA, Wong RKS, Rumble BR, Zuraw L (2004) Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Medicine 2:35

    Article  PubMed  Google Scholar 

  42. Gebski V, Burnmeister B, Smithers BM et al. (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet 8: 226–234

    Article  CAS  Google Scholar 

  43. http://www.snfge.asso.fr/01-Bibliotheque/0G-Thesauruscancerologie/publication5/sommaire-thesaurus.asp#1346

    Google Scholar 

  44. Ando N, Lizuka T, Ide H et al. (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 21: 4592–4596

    Article  PubMed  Google Scholar 

  45. Bosset JF, Gignoux M, Triboulet JP et al. (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the oesophagus. N Engl J Med 337: 161–167

    Article  PubMed  CAS  Google Scholar 

  46. Nygaard K, Hagen S, Hansen HS et al. (1992) Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16: 1104–1109

    Article  PubMed  CAS  Google Scholar 

  47. Urba SG, Orringer MB, Turrisi A et al. (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19: 305–313

    PubMed  CAS  Google Scholar 

  48. Apinop C, Putisak P, Preecha N. (1994) A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41: 391–393

    PubMed  CAS  Google Scholar 

  49. Le Prise E, Etienne P, Meunier B et al. (1994) A randomized study of chemotherapy, radiation therapy, anad surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73: 1779–1784

    Article  PubMed  Google Scholar 

  50. Burmeister B, Smithers M, Gebski V et al. (2005) A randomized phase III study comparing surgery alone versus chemoradiation therapy followed by surgery for respectable carcinoma of the oesophagus: an intergroup study of the trans-Tasman Radiation Oncology Group and the Australasian Gastro-Intestinal Trials Group. Lancet Oncol 6: 659–668

    Article  PubMed  Google Scholar 

  51. Lee J, Park S, Kim S et al. (2004) Agle institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15: 947–954

    Article  PubMed  CAS  Google Scholar 

  52. Walsh TN, Noonan N, Hollywood D et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462–467

    Article  PubMed  CAS  Google Scholar 

  53. Forastiere AA, Orringer MB, Perez-Tamayo C et al. (1993) Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 11: 1118–1123

    PubMed  CAS  Google Scholar 

  54. Herskovic A, Martz K, Al Sarraf M et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the oesophagus. N Engl J Med 326: 1593–1598

    Article  PubMed  CAS  Google Scholar 

  55. Bedenne L, Michel P, Bouche O et al. (2007) Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). J Clin Oncol 25:1160–1168

    Article  PubMed  CAS  Google Scholar 

  56. Stahl M, Stuschke M, Lehmann N et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23: 2310–2317

    Article  PubMed  Google Scholar 

  57. Crehange G, Bonnetain F, Seng S et al. (2007) Impact of radiation (RT) regimen on palliative procedures (PP) for patients with resectable locally advanced esophageal cancer treated with exclusive chemoradiation (CRT) or preoperative chemoradiation (CRT+S): results from a phase III trial of the Federation Francophone de Cancerologie Digestive (FFCD 9102). J Clin Oncol 25(18S): 205s

    Google Scholar 

  58. White RE, Parker RK, Kasepoi Z, Topazian M (2009) Stents as sole therapy for oesophageal cancer: a prospective analysis of outcomes after placement. Lancet Oncol 10: 240–246

    Article  PubMed  Google Scholar 

  59. McCaughan JS. (1999) Photodynamic thrapy for obstructive esophageal malignancies. Diagn Ther Endosc 5: 167–174

    Article  PubMed  CAS  Google Scholar 

  60. Chau I, Norman AR, Cunningham D et al. (2004) Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer—pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 22: 2395–2403

    Article  PubMed  Google Scholar 

  61. Di Fiore F, Lecleire S, Rigal O et al. (2006) Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 12: 4185–4190

    PubMed  Google Scholar 

  62. Michel P, Adenis A, Di Fiore F et al. (2006) Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. Br J Cancer 95: 705–709

    Article  PubMed  CAS  Google Scholar 

  63. Conroy T, Yataghene Y, Etienne PL et al. (2007) Definitive chemo-radiotherapy (CRT) with folfox 4 or 5FU-cisplatin as first line treatment for patients (pts) with inoperable esophageal cancer (IEC): Final results of a randomized phase II study. J Clin Oncol 25(18S): 205s

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’hépato-gastro-entérologie, Pôle viscéral, CHU Charles Nicolle, 1, rue Germont, 76000, Rouen

    P. Michel

  2. Unité d’oncologie uro-digestive, Pôle viscéral, CHU Charles Nicolle, 1, rue Germont, 76000, Rouen

    I. Iwanicki-Caron & F. Di Fiore

Authors
  1. P. Michel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Iwanicki-Caron
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Di Fiore
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France

About this chapter

Cite this chapter

Michel, P., Iwanicki-Caron, I., Di Fiore, F. (2011). Cancer de l’oesophage. In: Thérapeutique du cancer. Springer, Paris. https://doi.org/10.1007/978-2-8178-0021-9_21

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0021-9_21

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0020-2

  • Online ISBN: 978-2-8178-0021-9

Publish with us

Policies and ethics

Search

Navigation